David Gordon Farquhar

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

W. Kraus, C. Wahlestedt, A. Anighoro, 2022, eLife.

Decision letter: A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

W. Kraus, C. Wahlestedt, A. Anighoro, 2021 .